Ergotamine
Back to searchMolecule Structure
Scientific Name
Ergotamine
Description of the Drug
Ergotamine is an alpha-1 selective adrenergic agonist vasoconstrictor used to treat migraines with or without aura and cluster headaches.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00696
http://www.drugbank.ca/drugs/DB00696
Brand Name(s)
Not Available
Company Owner(s)
Organon Usa Inc, Hikma International Pharmaceuticals Llc, Sandoz Inc, Watson Laboratories Inc, Mikart Llc, Tersera Therapeutics Llc, Novartis Pharmaceuticals Corp, 3M Pharmaceuticals Inc, Cosette Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha | PROTEIN FAMILY | AGONIST | CHEMBL2095203 |
| Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1483 | |||
| PharmGKB | PA164747651 | |||
| Human Metabolome Database | HMDB0014834 | |||
| DrugBank | DB00696 | |||
| PubChem: Thomson Pharma | 14911400 | |||
| PubChem | 8223 | |||
| NMRShiftDB | 60059411 | |||
| Nikkaji | J2.889D | |||
| PDBe | ERM | |||
| BindingDB | 50027065 | |||
| EPA CompTox Dashboard | DTXSID9043774 | |||
| DrugCentral | 1043 | |||
| Metabolights | MTBLC64318 | |||
| Guide to Pharmacology | 149 | |||
| rxnorm | ERGOMAR | ERGOTAMINE TARTRATE | CAFERGOT | ERGOTAMINE |
| ChEBI | 64318 | |||
| ZINC | ZINC000052955754 |
